Literature DB >> 34023220

Genome editing by miniature CRISPR/Cas12f1 enzyme in Escherichia coli.

Kenji Okano1, Yu Sato2, Tatsuya Hizume3, Kohsuke Honda2.   

Abstract

The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system is a valuable genome editing tool for microorganisms. However, the commonly used Cas9 nuclease derived from Streptococcus pyogenes (SpCas9) is not applicable to many industrially relevant bacteria, due to its cytotoxicity and large size (1368 amino acids [aa]). We developed an alternative genome editing system using a miniature Cas12f1 nuclease (529 aa) derived from an uncultured archaeon, Un1Cas12f1. When editing four dispensable genes in Escherichia coli MG1655 and BW25113, the CRISPR/Un1Cas12f1 system showed higher efficiency (63%-100%) than the CRISPR/SpCas9 system (50%-79%). The CRISPR/Un1Cas12f1 genome editing system is expected to be applied to the genome editing of a wide variety of bacteria.
Copyright © 2021 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas12f1 nuclease; Genome editing; Protospacer-adjacent motif; sgRNA

Year:  2021        PMID: 34023220     DOI: 10.1016/j.jbiosc.2021.04.009

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  2 in total

Review 1.  Efficient Genome Editing by a Miniature CRISPR-AsCas12f1 Nuclease in Bacillus anthracis.

Authors:  Yanchun Wang; Shuli Sang; Xin Zhang; Haoxia Tao; Qing Guan; Chunjie Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-01-14

Review 2.  CRISPR based therapeutics: a new paradigm in cancer precision medicine.

Authors:  Shehnaz Bano; Prachi Kapse; Sumit Das; Gopal C Kundu
Journal:  Mol Cancer       Date:  2022-03-25       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.